ID   Huh7 IFITM2-/-
AC   CVCL_UZ56
DR   cancercelllines; CVCL_UZ56
DR   Wikidata; Q94308822
RX   PubMed=30723923;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 5413; IFITM2.
CC   Sequence variation: Mutation; HGNC; 6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 05-10-23; Version: 10
//
RX   PubMed=30723923; DOI=10.1002/hep.30548;
RA   Shi Y., Du L.-Y., Lv D.-D., Li H., Shang J., Lu J.-J., Zhou L.-Y.,
RA   Bai L., Tang H.;
RT   "Exosomal IFITM2 transmitted to DCs inhibits IFNalpha pathway
RT   activation and blocks anti-HBV efficacy of exogenous IFNalpha.";
RL   Hepatology 69:2396-2413(2019).
//